Bio-Optimized Berberine and the Bioavailability Problem: What a New 200 mg Study Really Shows
Berberine has a bioavailability problem: very little of an oral dose is absorbed. A new 200 mg bio-optimized trial reported metabolic benefits at a fraction of the usual dose. The honest read: promising, but one small, short, industry-funded study, and still not nature's Ozempic.
Read article →

